1 |
Hanawa H, Inomata T, Okura Y, Hirono S, Ogawa Y, Izumi T, Kodama M, Aizawa Y. T cells with similar Tcell receptor β-chain complementarity-determining region 3 motifs infiltrate inflammatory lesions of synthetic peptides inducing rat autoimmune myocarditis. Circ Res 1998, 83, 133-140.
DOI
ScienceOn
|
2 |
Ho VWH, Sly LM. Derivation and characterization of murine alternatively activated (M2) macrophages. Methods Mol Biol 2009, 531, 173-185.
DOI
ScienceOn
|
3 |
Ishiyama S, Hiroe M, Nishikawa T, Shimojo T, Abe S, Fujisaki H, Ito H, Yamakawa K, Kobayashi N, Kasajima T, Marumo F. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol 1998, 161, 4695-4701.
|
4 |
Johann AM, Barra V, Kuhn AM, Weigert A, von Knethen A, Brune B. Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production. FASEB J 2007, 21, 2704-2712.
DOI
ScienceOn
|
5 |
Kodama M, Matsumoto Y, Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 1992, 85, 1918-1926.
DOI
ScienceOn
|
6 |
Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990, 57, 250-262.
DOI
ScienceOn
|
7 |
Kodama M, Matsumoto Y, Fujiwara M, Zhang S, Hanawa H, Itoh E, Tsuda T, Izumi T, Shibata A. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 1991, 69, 1042-1050.
DOI
ScienceOn
|
8 |
Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27, 451-483.
DOI
ScienceOn
|
9 |
Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008, 13, 453-461.
DOI
|
10 |
Matsumoto Y. New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines. Curr Drug Targets Immune Endocr Metabol Disord 2005, 5, 73-77.
DOI
|
11 |
Mori M, Gotoh T. Arginine metabolic enzymes, nitric oxide and infection. J Nutr 2004, 134, 2820S-2825S.
DOI
|
12 |
Murakami U, Uchida K, Hiratsuka T. Cardiac myosin from pig heart ventricle. Purification and enzymatic properties. J Biochem 1976, 80, 611-619.
DOI
|
13 |
Neumann H, Kotter MR, Franklin RJM. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132, 288-295.
|
14 |
Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 1997, 29, 491-502.
DOI
|
15 |
Ratcliffe NR, Hutchins J, Barry B, Hickey WF. Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis. J Autoimmun 2000, 15, 359-367.
DOI
ScienceOn
|
16 |
Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 2001, 166, 2173-2177.
DOI
|
17 |
Shin T, Ahn M, Kim H, Kim HM, Matsumoto Y. Increased expression of osteopontin in the heart tissue of Lewis rats with experimental autoimmune myocarditis. J Vet Med Sci 2006, 68, 379-382.
DOI
ScienceOn
|
18 |
Suzuki J, Ogawa M, Watanabe R, Morishita R, Hirata Y, Nagai R, Isobe M. Autoimmune giant cell myocarditis - clinical characteristics, experimental models and future treatments. Expert Opin Ther Targets 2011, 15, 1163-1172.
DOI
ScienceOn
|
19 |
Shin T, Ahn M, Matsumoto Y. Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages. Anat Cell Biol 2012, 45, 141-148.
DOI
ScienceOn
|
20 |
Shin T, Tanuma N, Kim S, Jin J, Moon C, Kim K, Kohyama K, Matsumoto Y, Hyun B. An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats. J Neuroimmunol 1998, 92, 133-138.
DOI
ScienceOn
|
21 |
Suzuki K, Izumi T, Iwanaga T, Fujita T, Shibata A. Multinucleated giant cells undergoing apoptosis in experimental autoimmune myocarditis. Arch Histol Cytol 1995, 58, 231-241.
DOI
ScienceOn
|
22 |
Watanabe K, Sukumaran V, Veeraveedu PT, Thandavarayan RA, Gurusamy N, Ma M, Arozal W, Sari FR, Lakshmanan AP, Arumugam S, Soetikno V, Rajavel V, Suzuki K. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis. Inflamm Allergy Drug Targets 2011, 10, 218-225.
DOI
|
23 |
Cihakova D, Rose NR. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv Immunol 2008, 99, 95-114.
DOI
ScienceOn
|
24 |
Ahn M, Kim H, Matsumoto Y, Shin T. Increased expression of caveolin-1 and -2 in the hearts of Lewis rats with experimental autoimmune myocarditis. Autoimmunity 2006, 39, 489-495.
DOI
ScienceOn
|
25 |
Ahn M, Yang W, Kim H, Jin J, Moon C, Shin T. Immunohistochemical study of arginase-1 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. Brain Res 2012, 1453, 77-86.
DOI
ScienceOn
|
26 |
Blyszczuk P, Berthonneche C, Behnke S, Glonkler M, Moch H, Pedrazzini T, Lüscher TF, Eriksson U, Kania G. Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory progenitors into macrophages in experimental autoimmune myocarditis. Cardiovasc Res 2013, 97, 219-229.
DOI
ScienceOn
|
27 |
Gong D, Shi W, Yi S, Chen H, Groffen J, Heisterkamp N. signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol 2012, 13, 31.
DOI
ScienceOn
|
28 |
Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, Goerdt S. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001, 53, 386-392.
DOI
ScienceOn
|